Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 14 Projects
Project # Contact PI Funding Organization Fiscal Year
VGF and contactins in CSF/blood as novel synaptic marker candidates in dementias
#20059CB Patrick Öckl Alzheimer Forschung Initiative e. V. 2021
Individualized Alzheimer Research Criteria (IARC): a Dutch-German Initiative
#18002CB Kathrin Reetz Alzheimer Forschung Initiative e. V. 2018
Minimizing blood pressure variability with antihypertensive drugs to reduce dementia risk: an IPD meta-analysis of cohort studies in the CAPA consortium
GC-201711-2014067 Tully, Phillip Alzheimer's Drug Discovery Foundation 2018
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
Connection Between Depressive Symptoms and Dementia: When Best to Intervene.
GC-2013624 YAFFE, KRISTINE Alzheimer's Drug Discovery Foundation 2017
Effective clinical cancer treatment, care and management for people with comorbid cancer and dementia: understanding population demographics and intervention priorities and outcomes (CanDem-Int)
PB-PG-0816-20015 Professor Claire Surr UK National Institute for Health Research (NIHR) 2017
Systematic reviews of interventions which target modifiable risk factors for dementia
EUJPND-NIHR-McShane-2292 McShane, Rupert UK National Institute for Health Research (NIHR) 2016
English Longitudinal Study of Ageing (ELSA)
EUJPND-NIHR-Miss Joanna Lake-2295 Miss Joanna Lake UK National Institute for Health Research (NIHR) 2016
Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
EUJPND-NIHR-Savva-2312 Savva, George UK National Institute for Health Research (NIHR) 2016
Diabetes and Dementia: Identifying the optimal glycemic control patterns and treatment options to reduce risk
GC-2012486 Wainstein, Galit Alzheimer's Drug Discovery Foundation 2015